Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
UHS · NYSE · Health Care Facilities
Universal Health Services (UHS) · oqro.io/stocks/UHS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
No open-market purchase by an insider of Universal Health Services was filed in the last 90 days. The latest on record was on Dec 6, 2023.
Since 2006, Universal Health Services insiders reported 3 open-market purchases and 560 sales on Forms 4 and 5, with purchases in 2 different years, most recently 2023.
No open-market sale by an insider of Universal Health Services (UHS) was filed with the SEC in the last 90 days.
Yes. Members of Congress disclosed 3 trades in Universal Health Services (UHS) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent are from Sen. Alan Armstrong, Rep. Julia Letlow (LA05).
Universal Health Services's next results are expected on Feb 23, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
$186.07−5.91 (−3.08%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
−18.7% (−$42.77) from Nov 18, 2025 to Nov 18, 2026 · adjusted daily closes
Adjusted close went from $228.84 on Nov 18, 2025 to $186.07 on Nov 18, 2026 (−18.7%). Disclosed in this range: 2 insider trades, 0 pre-arranged insider sales, 1 Congress trade, and 23 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care Facilities company based in King of Prussia, Pennsylvania.
Last 12 months
−18.7%
Market value
$11B
S&P 500 +10.6% over the same dates. Prices adjusted for splits and dividends.
Short interest: 2.55M shares sold short (4.3% of shares outstanding), −3.5% vs the previous count, 3.6 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Revenue
$4.73B
+5.3% vs the same quarter a year earlier
Free cash flow, last 12 months
$1.12B
This quarter $422M, a year earlier $152M
Net debt
$5.53B
Debt $5.7B, cash $169M, at Sep 30, 2026
Net income, last 12 months
$1.46B
Operating profit covers interest 11.3x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 27, 2026.
Revenue, fiscal 2025
$17.4B
+9.7% vs the year before
Net income, fiscal 2025
$1.49B
As reported in the annual filing
Shares outstanding
58.9M
As of Jul 31, 2026
In fiscal 2025 the company spent $968M buying back its own shares and $51.3M on dividends. Cash actually paid, from its cash-flow statement.
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Fund moves
5 tracked managers disclosed the same change for Q2 2026. Among this manager's largest new positions for Q2 2026.
Fund moves
19 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Top officer leaving
“Peterson, Executive Vice President of the Company and President, Behavioral Health, who has been with the Company since 2019, submitted his resignation from his position with the Company, effective June 19, 2026 (“Effective Date”).”
8-K on sec.govTop officer leaving
“Miller will serve as CEO of the Company with a term scheduled to end on January 1, 2029, subject, however, to earlier termination, and subject further to automatic renewal for additional one-year periods unless either party elects otherwise.”
1 insider sold ~$852K in the 60 days before
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Insiders of Universal Health Services reported 3 open-market purchases and 560 sales since 2006; purchases in 2 different years, most recently 2023.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $128K2×2 trades |
| 2025 | — | $1.46M5×5 trades |
| 2024 | — | $15.6M19×19 trades |
| 2023 | $34K1×1 trade | $11.1M11×11 trades |
| 2022 | — | $383K3×3 trades |
| 2021 | — | $2.23M7×7 trades |
| 2020 | — | $435K3×3 trades |
| 2019 | — | $10.2M13×13 trades |
| 2017 | — | $1.24M1×1 trade |
| 2016 | — | $10.9M8×8 trades |
| 2015 | — | $5.48M24×24 trades |
| 2014 | $82K2×2 trades | $11.1M22×22 trades |
| 2013 | — | $15.5M37×37 trades |
| 2012 | — | $14.7M76×76 trades |
| 2011 | — | $3.69M52×52 trades |
| 2010 | — | $9.82M63×63 trades |
| 2009 | — | $7.98M74×74 trades |
| 2008 | — | $2.75M55×55 trades |
| 2007 | — | $2.86M32×32 trades |
| 2006 | — | $4.46M53×53 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Against the S&P 500 over the year
Since Nov 13, 2025, UHS is down 13.1% and the index fund is up 10.1%: 23 points behind the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much UHS moves
End-of-day prices. These figures describe the past year and say nothing about what comes next.
First Eagle Investment Management, LLC
Schedule 13G: passive · filed Aug 6, 2026 · 4.67M shares
Vanguard Capital Management
Schedule 13G: passive · filed Apr 30, 2026 · 3.92M shares
Dimensional Fund Advisors LP
Schedule 13G: passive · filed Oct 8, 2026 · 2.68M shares
PZENA INVESTMENT MANAGEMENT LLC
Schedule 13G: passive · filed Oct 19, 2026 · 2.64M shares
Anyone owning more than 5% must file within days. Structured filings have existed since December 2024, so older stakes that were never amended may be missing.
Last results
Oct 27, 2026
Within the 30 days after it, until Nov 26, 2026
Next results, expected
Feb 23, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
Not enough history
From Universal Health Services's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Universal Health Services's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Short sale volume: 69.2% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 66.1%. FINRA daily files, to Nov 18, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.